• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌水肿对肥厚型心肌病预后的渐进意义。

Incremental significance of myocardial oedema for prognosis in hypertrophic cardiomyopathy.

机构信息

Department of Radiology, West China Hospital, Sichuan University, Chengdu, Sichuan, P. R. China.

Department of Cardiology, West China Hospital, Sichuan University, Guoxue Xiang No. 37, Chengdu, Sichuan 610041, P. R. China.

出版信息

Eur Heart J Cardiovasc Imaging. 2023 Jun 21;24(7):876-884. doi: 10.1093/ehjci/jead065.

DOI:10.1093/ehjci/jead065
PMID:37073085
Abstract

AIMS

To explore the prognosis of myocardial oedema measured by T2 mapping in hypertrophic cardiomyopathy (HCM).

METHODS AND RESULTS

A total of 674 patients with HCM (age: 50 ± 15 years, 60.5% males) who underwent cardiovascular magnetic resonance were prospectively enrolled from 2011 to 2020. One hundred healthy controls (age: 48 ± 19 years, 58.0% males) were included for comparison. Myocardial oedema was quantitatively measured by T2 mapping in both global and segmental myocardium. The endpoints were defined as a combination of cardiovascular death and appropriate implantable cardioverter defibrillator discharge. During a median follow-up of 36 months (interquartile range: 24-60 months), 55 patients (8.2%) had cardiovascular events. Patients with cardiovascular events had a higher T2 max, T2 min, and T2 global values (all P < 0.001) than patients who remained event free. Survival analysis demonstrated that patients with HCM with late gadolinium enhancement [LGE(+)] and T2 max ≥44.9 ms had a higher risk of developing cardiovascular events (P < 0.001). A multivariate Cox regression analysis showed that T2 max, T2 min, and T2 global provided significant prognostic value to predict cardiovascular events (all P < 0.001). According to the C-index (0.825, 0.814), net reclassification index (0.612, 0.536, both P < 0.001), and integrative discrimination index (0.029, 0.029, both P < 0.05), T2 max or T2 min significantly increased the predictive performance of established risk factors, including extensive LGE.

CONCLUSION

Patients with HCM with LGE(+) and higher T2 had worse prognosis than those with LGE(+) and lower T2.

摘要

目的

探讨 T2 映射测量肥厚型心肌病(HCM)心肌水肿的预后。

方法和结果

前瞻性纳入 2011 年至 2020 年期间接受心血管磁共振检查的 674 例 HCM 患者(年龄:50 ± 15 岁,60.5%为男性),并纳入 100 名健康对照者(年龄:48 ± 19 岁,58.0%为男性)进行比较。通过 T2 映射对整体和节段心肌进行定量测量心肌水肿。终点定义为心血管死亡和适当植入式心脏复律除颤器放电的组合。在中位数为 36 个月(四分位距:24-60 个月)的随访期间,55 例患者(8.2%)发生心血管事件。发生心血管事件的患者 T2max、T2min 和 T2 全局值均高于无事件患者(均 P < 0.001)。生存分析表明,具有晚期钆增强 [LGE(+)] 和 T2max≥44.9ms 的 HCM 患者发生心血管事件的风险更高(P < 0.001)。多变量 Cox 回归分析表明,T2max、T2min 和 T2 全局值对预测心血管事件具有显著的预后价值(均 P < 0.001)。根据 C 指数(0.825、0.814)、净重新分类指数(0.612、0.536,均 P < 0.001)和综合判别指数(0.029、0.029,均 P < 0.05),T2max 或 T2min 显著提高了包括广泛 LGE 在内的既定危险因素的预测性能。

结论

与 LGE(+)和较低 T2 的 HCM 患者相比,具有 LGE(+)和较高 T2 的 HCM 患者预后更差。

相似文献

1
Incremental significance of myocardial oedema for prognosis in hypertrophic cardiomyopathy.心肌水肿对肥厚型心肌病预后的渐进意义。
Eur Heart J Cardiovasc Imaging. 2023 Jun 21;24(7):876-884. doi: 10.1093/ehjci/jead065.
2
Late Gadolinium Enhancement-Dispersion Mapping: A New Magnetic Resonance Imaging Technique to Assess Prognosis in Patients With Hypertrophic Cardiomyopathy and Low-Intermediate 5-Year Risk of Sudden Death.晚期钆增强弥散映射:一种新的磁共振成像技术,用于评估中低 5 年猝死风险的肥厚型心肌病患者的预后。
Circ Cardiovasc Imaging. 2020 Jun;13(6):e010489. doi: 10.1161/CIRCIMAGING.120.010489. Epub 2020 Jun 16.
3
The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.心脏磁共振成像在肥厚型心肌病患者心源性猝死风险分层中的价值及延迟钆增强分布情况
J Cardiol. 2016 Jul;68(1):49-56. doi: 10.1016/j.jjcc.2015.07.020. Epub 2015 Sep 9.
4
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.定量对比增强心血管磁共振对肥厚型心肌病患者猝死风险评估的预后价值。
Circulation. 2014 Aug 5;130(6):484-95. doi: 10.1161/CIRCULATIONAHA.113.007094.
5
Prognostic value of myocardial extracellular volume fraction evaluation based on cardiac magnetic resonance T1 mapping with T1 long and short in hypertrophic cardiomyopathy.基于心脏磁共振 T1 mapping 测量长、短 T1 值的心肌细胞外容积分数评价对肥厚型心肌病的预后价值。
Eur Radiol. 2021 Jul;31(7):4557-4567. doi: 10.1007/s00330-020-07650-7. Epub 2021 Jan 15.
6
Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy.晚期钆增强在肥厚型心肌病临床结局中的预测价值。
JACC Cardiovasc Imaging. 2012 Apr;5(4):370-7. doi: 10.1016/j.jcmg.2011.11.021.
7
ESC sudden-death risk model in hypertrophic cardiomyopathy: Incremental value of quantitative contrast-enhanced CMR in intermediate-risk patients.肥厚型心肌病的ESC猝死风险模型:定量对比增强CMR在中危患者中的增量价值。
Clin Cardiol. 2017 Oct;40(10):853-860. doi: 10.1002/clc.22735. Epub 2017 Jun 14.
8
Radiomics of Late Gadolinium Enhancement Reveals Prognostic Value of Myocardial Scar Heterogeneity in Hypertrophic Cardiomyopathy.钆延迟强化的影像组学揭示肥厚型心肌病中心肌瘢痕异质性的预后价值
JACC Cardiovasc Imaging. 2024 Jan;17(1):16-27. doi: 10.1016/j.jcmg.2023.05.003. Epub 2023 Jun 21.
9
High Signal Intensity on T2-Weighted Cardiovascular Magnetic Resonance Imaging Predicts Life-Threatening Arrhythmic Events in Hypertrophic Cardiomyopathy Patients.T2 加权心血管磁共振成像上的高信号强度可预测肥厚型心肌病患者的危及生命的心律失常事件。
Circ J. 2018 Mar 23;82(4):1062-1069. doi: 10.1253/circj.CJ-17-1235. Epub 2018 Feb 21.
10
The Clinical Prognosis of Presence and Location of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Imaging in Patients with Hypertrophic Cardiomyopathy: a Single-Center Cohort Study.心脏磁共振成像在肥厚型心肌病患者中晚期钆增强的存在和位置的临床预后:一项单中心队列研究。
J Cardiovasc Transl Res. 2021 Oct;14(5):1001-1016. doi: 10.1007/s12265-021-10107-x. Epub 2021 Feb 24.

引用本文的文献

1
Impact of glucose metabolism on myocardial fibrosis and inflammation in hypertrophic cardiomyopathy: a cardiac MR study.葡萄糖代谢对肥厚型心肌病中心肌纤维化和炎症的影响:一项心脏磁共振研究。
Front Endocrinol (Lausanne). 2025 Aug 26;16:1653927. doi: 10.3389/fendo.2025.1653927. eCollection 2025.
2
Hypertrophic cardiomyopathy.肥厚型心肌病
Nat Rev Dis Primers. 2025 Aug 14;11(1):58. doi: 10.1038/s41572-025-00643-0.
3
Cardiac Magnetic Resonance Imaging and Arrhythmic Risk Stratification in Cardiomyopathies.心肌病的心脏磁共振成像与心律失常风险分层
J Clin Med. 2025 Jul 11;14(14):4922. doi: 10.3390/jcm14144922.
4
Cardiac Magnetic Resonance in the Evaluation and Management of Nonischemic Cardiomyopathies.心脏磁共振成像在非缺血性心肌病评估与管理中的应用
JACC Heart Fail. 2025 Sep;13(9):102525. doi: 10.1016/j.jchf.2025.102525. Epub 2025 Jul 5.
5
Lateral hypertrophic cardiomyopathy: A case report.肥厚型心肌病:一例病例报告。
Heliyon. 2024 Oct 19;10(20):e38919. doi: 10.1016/j.heliyon.2024.e38919. eCollection 2024 Oct 30.
6
Cardiovascular imaging research and innovation in 2023.2023年心血管成像研究与创新
Eur Heart J Imaging Methods Pract. 2024 Apr 18;2(1):qyae029. doi: 10.1093/ehjimp/qyae029. eCollection 2024 Jan.
7
Multiparametric Mapping via Cardiovascular Magnetic Resonance in the Risk Stratification of Ventricular Arrhythmias and Sudden Cardiac Death.多参数心血管磁共振映射在心律失常和心脏性猝死风险分层中的应用。
Medicina (Kaunas). 2024 Apr 24;60(5):691. doi: 10.3390/medicina60050691.
8
Fabry Disease: More than a Phenocopy of Hypertrophic Cardiomyopathy.法布里病:不仅仅是肥厚型心肌病的拟表型
J Clin Med. 2023 Nov 13;12(22):7061. doi: 10.3390/jcm12227061.
9
Reference ranges of myocardial T1 and T2 mapping in healthy Chinese adults: a multicenter 3T cardiovascular magnetic resonance study.健康中国成年人心肌 T1 和 T2 映射的参考范围:一项多中心 3T 心血管磁共振研究。
J Cardiovasc Magn Reson. 2023 Nov 16;25(1):64. doi: 10.1186/s12968-023-00974-5.
10
Mitochondrial Cardiomyopathy Due to the Variant m.4300A>G Requires Comprehensive Clinical and Genetic Workup.由m.4300A>G变异导致的线粒体心肌病需要全面的临床和基因检查。
Radiol Cardiothorac Imaging. 2023 Aug 17;5(4):e230144. doi: 10.1148/ryct.230144. eCollection 2023 Aug.